Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

New guidelines help interventional cardiologists manage chronic venous disease
"These recommendations will help ensure that patient care remains both consistent and personalized," SCAI President Srihari S. Naidu, MD, explained.
Private equity firm jumps into vascular health with new investment
Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.
New report raises questions about data that helped heart drug gain FDA approval
Ticagrelor, an antiplatelet medication from AstraZeneca commonly prescribed by cardiologists, gained FDA approval back in 2011. The author of a new investigative report, however, is raising several concerns about the data used to secure that approval.
Popular obesity drugs limit amputations, heart issues among patients with peripheral artery disease
Semaglutide, tirzepatide and other GLP-1 drugs appear to provide significant value for patients with moderate PAD.
Angiographic catheters recalled due to safety risk
The new Class I recall includes nearly 27,000 devices that could potentially experience a harmful defect during use.

‘We have never seen anything like this’: Risk of death 74% higher when COVID-19 patients develop blood clots

Blood clots are unusually common—and quite fatal—among patients hospitalized with COVID-19.

Aggressive anticoagulation strategies may be harmful for COVID-19 patients

Anticoagulation therapies are an important part of treating COVID-19 patients—but there appears to be no benefit to taking a more aggressive approach.

Long-term anticoagulation a safe treatment option for elderly AFib patients

Long-term anticoagulation can be recommended for AFib patients 90 years old and older, according to new research.

Risk of death, disability after stroke much higher for COVID-19 patients

Experiencing a stroke while your body is already battling COVID-19 can be especially dangerous, this new study suggests.

Cardiologists detail why blood clots are so common among COVID-19 patients

"In patients with COVID-19, we continue to see a relentless, self-amplifying cycle of inflammation and clotting in the body," one researcher said.

Boston Scientific gains FDA approval for Ranger drug-coated balloon

The newly approved solution was designed for the treatment of patients with PAD in the superficial femoral artery and proximal popliteal artery.

American Heart Association, Society of Vascular and Interventional Neurology launch online-only journal

The journal is expected to begin publishing by early 2021.

Medtronic’s new stent system for deep venous obstruction gains FDA approval

The approval comes after Medtronic reported the successful results of a clinical study focused on 200 patients.

Vascular & Endovascular

New guidelines help interventional cardiologists manage chronic venous disease

Private equity firm jumps into vascular health with new investment

New report raises questions about data that helped heart drug gain FDA approval

Popular obesity drugs limit amputations, heart issues among patients with peripheral artery disease

Angiographic catheters recalled due to safety risk